Pharmaceutical company Merck says that it will stop using chimpanzees in its biomedical research efforts, according to the Wall Street Journal. The company says newer technologies and alternate approaches can replace the use of chimpanzees in drug research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Chimps' Retirement

This Week in Science

Changes to Gut Bugs

Academic Image

Long-time Companion

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.